PAN HR Solution Limited, a specialized B2B manpower provider with over 10,000 personnel deployed nationwide, has launched its ₹17.04 crore SME IPO. With a price band of ₹74 to ₹78, this blog analyzes the company’s transition to a high-margin "Pay and Collect" model, its 99% revenue dependency on top clients, and the current flat GMP status.
Aye Finance, a prominent NBFC backed by Google’s parent company Alphabet (via CapitalG) and Elevation Capital, is set to open its ₹1,010 crore IPO on February 9, 2026. This blog covers the fixed price band of ₹122–₹129, the company’s "cluster-based" lending model, and the latest Grey Market Premium (GMP) signals.
Fractal Analytics, a global leader in artificial intelligence and decision sciences, has officially set its IPO price band at ₹857 to ₹900 per share. With the issue opening on February 9, 2026, this ₹2,834 crore IPO marks a landmark moment for India’s deep-tech sector. Read the full financial analysis, GMP updates, and strategic growth plans for this "Magnificent 7" partner.
Brandman Retail Limited, a premier distributor of global athleisure brands like New Balance and Salomon, is launching its ₹86.09 crore SME IPO tomorrow, February 4, 2026. With an asset-light model and a massive 153% jump in profit, this post explores the company’s "Sneakrz" multi-brand strategy and whether the ₹2.81 lakh entry price is worth the stride.
Biopol Chemicals Limited, a leading manufacturer of specialty chemicals for textiles, home care, and agriculture, is launching its ₹31.26 crore SME IPO on February 6, 2026. This blog breaks down the company’s strong financial trajectory, its transition from the legacy "United Chemical Company," and the key risks and rewards for investors looking at the chemical sector.
Msafe Equipments Limited, a leader in aluminum scaffolding and height-safety solutions, is currently live with its ₹66.42 crore IPO. With the bidding ending tomorrow, January 30, this post breaks down the company’s impressive 48% revenue growth, its expansion into a new Greater Noida facility, and the current Grey Market Premium (GMP) as it targets a listing on the BSE SME platform.
Kanishk Aluminium India Limited, a Jodhpur-based manufacturer of aluminium extrusions and the name behind the premium "Baari" brand, is currently live with its ₹29.20 crore IPO. With the bidding closing tomorrow, January 30, this post analyzes the company's transition to a debt-free balance sheet, its growing presence in the solar and architectural sectors, and the current flat GMP status.
Shayona Engineering Limited, a diversified manufacturer of precision castings and piping systems, has concluded its bidding window today. With a fresh issue size of ₹14.86 crore and a focus on industrial automation and infrastructure, this blog analyzes the final subscription trends, financial growth, and what investors should expect for the listing on January 30, 2026.
Kasturi Metal Composite Limited, an Amravati-based manufacturer of steel fibers and steel wool for the construction and automotive sectors, has launched its ₹17.61 crore SME IPO. This post explores the company’s expansion into a new 6,000 MT capacity unit, its niche "Duraflex" brand, and the key financial metrics you need to know before the issue closes on January 29, 2026.
Hannah Joseph Hospital Limited, a premier neurology and multi-specialty healthcare provider in South Tamil Nadu, is concluding its ₹42 crore SME IPO today. This post provides a final look at the subscription trends, the hospital's ambitious expansion into radiation oncology, and the essential timelines for allotment and listing on January 30, 2026.
Kasturi Metal Composite Limited, a specialized manufacturer of steel fibers and steel wool for critical infrastructure, is concluding its ₹17.61 crore SME IPO today. This post provides the final subscription trends, a deep dive into the company's aggressive capacity expansion, and the crucial listing strategy for investors ahead of its February 3, 2026 debut.
Accretion Nutraveda Limited, a Gujarat-based healthcare manufacturer specializing in over 400 Ayurvedic and nutraceutical formulations, is launching its ₹24.77 crore SME IPO. This post breaks down the company’s massive revenue growth, its global footprint across 20+ countries, and the essential bidding details for investors looking to participate between January 27 and January 30, 2026.